LASER VISION CENTERS INC
10-Q/A, 1999-04-22
OFFICES & CLINICS OF DOCTORS OF MEDICINE
Previous: LASER VISION CENTERS INC, 10-Q/A, 1999-04-22
Next: LASER VISION CENTERS INC, 10-Q/A, 1999-04-22



<PAGE>   1


                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-Q/A


      X-QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(b) OF THE SECURITIES
              EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED
                                OCTOBER 31, 1997


                         Commission file number 1-10629

                           LASER VISION CENTERS, INC.
             (Exact name of registrant as specified in its charter)


               Delaware                                   43-1530063
               --------                                   ----------
(State or other jurisdiction of incorporation  (I.R.S. Employer identification
or organization)                               number)


        540 Maryville Centre Dr., Suite 200,  St. Louis, Missouri 63141
        ---------------------------------------------------------------
                    (Address of principal executive offices)


                                 (314)434-6900
                                 -------------
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934  during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes  X  No    
                                              ---    ---

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.

Common Stock outstanding as of November 28, 1997 - 9,283,070 shares.

Reason for Amendment
   

The Company has restated its financial statements as of and for the six month
period ended October 31, 1997 to account for the beneficial conversion feature
and the mandatory redemption features of the Series B Convertible Preferred
Stock. See Note 2 to the Financial Statements.
    








<PAGE>   2


                           LASER VISION CENTERS, INC.
             FORM 10-Q/A FOR QUARTERLY PERIOD ENDED OCTOBER 31, 1997
                                     INDEX



<TABLE>
<CAPTION>
PART OR ITEM                                                                           PAGE
<S>                                                                                  <C>        

Part I.  FINANCIAL STATEMENTS                                                                     
   
                                                                                                  
Item 1.  Interim Consolidated Financial Statements                                                
                                                                                                  
         Consolidated Balance Sheet  - October 31, 1997 and April 30, 1997 ............. 3-4   
                                                                                                  
         Consolidated Statement of Operations - Three months and six months                       
         ended October 31, 1997 ........................................................ 5     
                                                                                                  
         Consolidated Statement of Cash Flow - Six months                                         
         ended October 31, 1997 and  1996 .............................................. 6-7   
                                                                                                  
         Consolidated Statement of Changes in Stockholders' Equity - Six months                   
         ended October 31, 1997 ........................................................ 8     
                                                                                                  
         Notes to Interim Consolidated Financial Statements ...........................  9-10
                                                                                                  
Item 2.  Management's Discussion and Analysis of                                                  
                                                                                                  
         Financial Condition and Results of Operations                                            
                                                                                                  
         Liquidity and Capital Resources .............................................   10-11
                                                                                                  
         Results of Operations .......................................................   11-14
                                                                                                 
Part II. OTHER INFORMATION
         
Item 1.  Legal Proceedings ............................................................  15
         
Item 2.  Changes in Securities ........................................................  15
         
Item 3.  Defaults upon Senior Securities ..............................................  15
         
Item 4.  Submission of Matters to a
         Vote of Security Holders ...................................................... 15

Item 5.  Other Information ............................................................. 15

Item 6.  Reports on Form 8-K ........................................................... 15
</TABLE>
    



<PAGE>   3



LASER VISION CENTERS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
- -------------------------------------------
<TABLE>
<CAPTION>

                                                           (UNAUDITED)                                   
                                                            October 31,     April 30,           
                                                               1997            1997         
<S>                                                    <C>                <C>
CURRENT ASSETS
- --------------
      Cash and cash equivalents                            $ 7,675,000     $ 3,794,000       
      Restricted cash                                          411,000         461,000       
      Receivables, net of allowances of                                                      
       $469,000 and $360,000, respectively                   3,047,000       1,719,000       
      Prepaid expenses and                                                                   
       other current assets                                  1,682,000         915,000       
                                                           -----------     -----------       

                                Total Current Assets        12,815,000       6,889,000

EQUIPMENT
- ---------
      Laser equipment                                       13,926,000      12,617,000            
      Medical Equipment                                        762,000         750,000            
      Mobile equipment                                       2,691,000       1,599,000            
      Furniture and fixtures                                 1,381,000       1,316,000            
      -Accumulated depreciation                             (5,896,000)     (3,799,000)           
                                                           -----------     -----------            
                                                                                                   
                                Total Equipment, Net        12,864,000      12,483,000

OTHER ASSETS
- ------------
      Restricted cash                                        1,136,000       1,239,000
      Goodwill, net                                            757,000         836,000
      Tradename and service mark costs, net                    126,000         136,000
      Deferred contract rights                               1,655,000       1,238,000
      Rent deposits and other, net                              61,000          49,000
                                                           -----------     -----------
                                                                                      
                                Total Other Assets           3,735,000       3,498,000
                                                           -----------     -----------

                                       Total Assets        $29,414,000     $22,870,000
                                                           ===========     ===========
</TABLE>




See notes to interim consolidated financial statements







                                       3



<PAGE>   4





LASER VISION CENTERS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
- -------------------------------------------

<TABLE>
<CAPTION>

                                                               (UNAUDITED)                       
                                                                October 31,    April 30,        
                                                                  1997            1997           
<S>                                                          <C>              <C>                         
CURRENT LIABILITIES                                         (Restated-Note 2)  
- -------------------                                                                              
      Current portion of notes payable                        $ 1,501,000      $ 1,003,000       
      Current portion of capitalized                                                             
       lease obligations                                          783,000          690,000       
      Accounts payable                                          3,110,000        2,078,000       
      Accrued compensation                                        532,000          616,000       
      Other accrued liabilities                                   979,000          848,000       
                                                              -----------      -----------       
                                                                                                 
                                Total Current Liabilities       6,905,000        5,235,000       

NON-CURRENT LIABILITIES
- -----------------------
      Notes payable                                             5,423,000        4,544,000
      Capitalized lease obligations                             1,157,000        1,589,000
      Deferred revenue                                             91,000          134,000
                                                              -----------      -----------       
                            Total Non-Current Liabilities       6,671,000        6,267,000

COMMITMENTS AND CONTINGENCIES

COMMON STOCK AND STOCK OPTIONS ISSUED
 FOR CONTRACT RIGHTS                                            1,618,000        1,092,000
   

SERIES B CONVERTIBLE PREFERRED STOCK 
WITH MANDATORY REDEMPTION PROVISIONS (Restated-Note 2)          2,557,000 

STOCKHOLDERS' EQUITY
- --------------------
Common stock, par value of $.01 per
 share, 50,000,000 shares authorized;
 9,282,070 and 8,817,057 shares issued
 and outstanding, respectively                                     93,000           88,000
Warrants and options (Restated-Note 2)                            318,000           36,000
Paid-in capital (Restated-Note 2)                              42,473,000       38,663,000
Accumulated deficit                                           (31,221,000)     (28,511,000)
                                                              -----------      -----------       
                                Total Stockholders' Equity     11,663,000       10,276,000
                                                              -----------      -----------       

                Total Liabilities and  Equity                 $29,414,000       $22,870,000
                                                             ===========       ===========
</TABLE>
    



See notes to interim consolidated financial statements


                                       4



<PAGE>   5


LASER VISION CENTERS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED)
- ------------------------------------------------

<TABLE>
<CAPTION>
                                                            Three Month Period               Six Month Period   
                                                            Ended October 31,                Ended October 31,  
                                                            1997         1996                1997         1996  
                                                                                      (Restated-Note 2)    

<S>                                                      <C>         <C>                <C>              <C>
REVENUES                                                 $ 5,224,000   $ 1,928,000        $ 9,321,000      $ 3,430,000
Cost of revenues, depreciation                                                       
  and amortization                                         1,077,000       944,000          2,122,000        1,559,000
Cost of revenues, other                                    2,871,000       886,000          5,142,000        1,663,000
                                                         -----------   -----------        -----------      ----------- 

                        GROSS PROFIT                       1,276,000        98,000          2,057,000          208,000
                                                         -----------   -----------        -----------      ----------- 

Operating Expenses:    
 General and administrative                                  745,000       785,000          1,533,000        1,892,000
 Salaries and related expenses                             1,067,000       815,000          1,941,000        1,622,000
 Depreciation and amortization                               134,000       109,000            250,000          208,000
 Selling and marketing expenses                              363,000       520,000            716,000          991,000
                                                         -----------   -----------        -----------      ----------- 

                                                           2,309,000     2,229,000          4,440,000        4,713,000
                                                         -----------   -----------        -----------      ----------- 

                        LOSS FROM OPERATIONS              (1,033,000)   (2,131,000)        (2,383,000)      (4,505,000)
Other income (expenses)  
 Interest and other income                                    89,000        57,000            144,000          163,000
 Interest expense                                           (229,000)     (117,000)          (471,000)        (189,000)
 Minority interest in net loss   
  of subsidiary                                                             55,000                             103,000
                                                         -----------   -----------        -----------      ----------- 
                                 
                                NET LOSS                 ($1,173,000)  ($2,136,000)       ($2,710,000)     ($4,428,000)
                                                         ===========   ===========        ===========      ===========
                                 
                        NET LOSS PER SHARE 
                          (Restated-Note 2)                   ($0.14)       ($0.25)            ($0.51)          ($0.57)
                                                         ===========   ===========        ===========      ===========
                                 
Weighted average number of       
 common shares outstanding                                 9,044,000     8,537,000          8,933,000        8,035,000
                                                         ===========   ===========        ===========      ===========
</TABLE>                                                                     
                                                                             
See notes to interim consolidated financial statements



                                       5



<PAGE>   6


<TABLE>
<CAPTION>
LASER VISION CENTERS, INC. AND SUBSIDIARIES                               Six Month Period
CONSOLIDATED STATEMENT OF CASH FLOW (UNAUDITED)                           Ended October 31,
- -----------------------------------------------
                                                                        1997              1996
<S>                                                                <C>              <C>
CASH FLOWS FROM OPERATING ACTIVITIES
- ------------------------------------
 Net loss                                                            ($2,710,000)    ($4,428,000)
 Adjustments to reconcile net loss to net cash
      used in operating activities:
        Depreciation and amortization                                  2,372,000       1,767,000
        Compensation paid in common stock,
            options or warrants                                           66,000
        Provision for uncollectible accounts                             109,000         108,000
        Receivables increase                                          (1,437,000)       (371,000)
        Prepaid expenses and other current asset increase               (767,000)       (163,000)
        Minority interests decrease                                                     (103,000)
        Accounts payable and accrued
          liabilities increase                                         1,080,000         198,000
        Deferred revenue decrease                                        (43,000)        (49,000)
                                                                     -----------     -----------
 Net cash used in operating activities                                (1,330,000)     (3,041,000)

CASH FLOWS FROM INVESTING ACTIVITIES
- ------------------------------------
 Acquisition of equipment                                             (2,553,000)     (3,844,000)
 Acquisition of goodwill                                                                (206,000)
 Other, net                                                              (14,000)         22,000
                                                                     -----------     -----------
Net cash used in investing activities                                 (2,567,000)     (4,028,000)

CASH FLOWS FROM FINANCING ACTIVITIES
- ------------------------------------
Proceeds from private offering, preferred                              6,000,000  
Private placement offering costs, preferred                             (513,000)  
Return of restricted cash                                                153,000    
Proceeds from exercise of stock options                                  284,000          60,000
Proceeds from exercise of Class C and
 Class E warrants                                                        111,000
Proceeds from exercise of other warrants                                 706,000
Principal payments under capitalized
 lease obligations and notes payable                                    (826,000)     (2,109,000)
Proceeds from loan financings                                          1,863,000       2,573,000
                                                                     -----------     -----------
Net cash provided by financing activities                              7,778,000         524,000
                                                                     -----------     -----------
                NET INCREASE (DECREASE) IN CASH
                        AND CASH EQUIVALENTS                           3,881,000      (6,545,000)

Cash and cash equivalents at beginning of period                       3,794,000      12,672,000
                                                                     -----------     -----------

CASH AND CASH EQUIVALENTS AT END OF PERIOD                           $ 7,675,000     $ 6,127,000
                                                                     ===========     ===========
</TABLE>


                                       6



<PAGE>   7
   
<TABLE>
<CAPTION>
LASER VISION CENTERS, INC. AND SUBSIDIARIES                                  Six Month Period               
CONSOLIDATED STATEMENT OF CASH FLOW                                          Ended October 31,              
- -------------------------------------------                                1997             1996            
<S>                                                                   <C>             <C>                            
Non-cash investing and financing:                               (Restated-Note 2)
- ---------------------------------
   Conversion of preferred stock to common stock,
    (Restated-Note 2)                                                  $  849,000        $14,665,000
   Deemed preferred dividends (Restated-Note 2)                        $1,831,000            126,000
   Adjustment of value of common stock and                                                                   
     stock options issued for contract rights                             526,000                            
   Equipment deposits and assets held for sale                                                               
    exchanged for equipment                                                                2,693,000         
   Restricted cash acquired through financing                                              1,650,000         
   Capital lease obligations related to laser purchases                                      617,000         
   Increase in other liabilities for laser purchase                                          300,000         
   Common stock issued to acquire goodwill and                                                               
    reduce liabilities                                                                       200,000         
   </TABLE> 
    
            

See notes to interim consolidated financial statements


                                       7





<PAGE>   8


LASER VISION CENTERS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)
- ---------------------------------------------------------------------
(Restated -- Note 2)


   
<TABLE>
<CAPTION>
                        
                                    COMMON STOCK                                            
                                   $.01 PAR VALUE       PAID-IN      WARRANTS AND   ACCUMULATED   TOTAL SHAREHOLDERS'
                                  SHARES     AMOUNT     CAPITAL        OPTIONS        DEFICIT           EQUITY
<S>                              <C>         <C>        <C>           <C>         <C>            <C>
Balance - April 30, 1997         8,817,057   $88,000  $38,663,000       $ 36,000    ($28,511,000)   $10,276,000
Issuance of Warrants
and Preferred Stock with   
beneficial conversion features
(Restated-Note 2)                                       3,667,000        245,000                      3,912,000           
Exercise of incentive options       61,800     1,000      283,000                                       284,000
Exercise of non-qualified   
warrants                           140,700     2,000      704,000                                       706,000
Exercise of Class E and     
Class C warrants                    24,208                111,000                                       111,000
Deemed dividends on        
convertible preferred stock
(Restated-Note 2)                                      (1,831,000)                                   (1,831,000) 
Conversion of preferred stock
(Restated-Note 2)                  234,464     2,000      847,000                                       849,000
Warrants and Options                                                      37,000                         37,000
Shares issued to 401(k) plan
for employees                        3,841                 29,000                                        29,000
Net loss for the six month  
period ending October 31,   
1997                                                                                  (2,710,000)     (2,710,000)
                                 ---------   -------  ------------      --------     ------------    -----------
Balance - October 31, 1997       9,282,070   $93,000  $ 42,473,000      $318,000    ($31,221,000)    $11,663,000
          (Restated-Note 2)      =========   =======  ============      ========     ============    ===========
</TABLE>      
    

See notes to interim consolidated financial statements


                                       8



<PAGE>   9



     LASER VISION CENTERS, INC. AND SUBSIDIARIES

               NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

                                OCTOBER 31, 1997
                                  (Unaudited)

Item 1.
1. The information contained in the interim consolidated financial statements
and footnotes is condensed from that which would appear in the annual
consolidated financial statements.  Accordingly, the interim consolidated
financial statements included herein should be read in conjunction with the
consolidated financial statements and related notes thereto contained in the
April 30, 1997 Annual Report on Form 10-K filed by Laser Vision Centers, Inc.
(the "Company") with the Securities and Exchange Commission.  The unaudited
interim consolidated financial statements as of October 31, 1997 and October
31, 1996, and for the quarterly and six month periods then ended, include all
normal recurring adjustments which management considers necessary for a fair
presentation.  The results of operations for the interim periods are not
necessarily indicative of the results which may be expected for the entire
fiscal year.  The interim consolidated financial statements include the
accounts and transactions of the Company and its subsidiaries.  All significant
intercompany transactions and accounts have been eliminated.  The October 31,
1997 six month consolidated statements of operations include certain
reclassifications to conform with classifications for the three month period
ended October 31, 1997.

The net loss per share was computed using the weighted average number of common
shares outstanding during each period.  Common stock equivalents were excluded
due to their anti-dilutive effect.  The loss per common share for the six months
ended October 31, 1997 and for the quarter ended October 31, 1997, reflects
$1,831,000 and $66,000, respectively, of deemed dividends on the Series B
Convertible Preferred Stock (See Note 2).  The loss per common share for the six
months ended October 31, 1996 and for the quarter ended October 31, 1996
reflects $126,000 and $21,000, respectively, of accrued dividends on Convertible
Preferred Stock with Mandatory Redemption in 2005.

   
2. In the course of a review of a Securities Act filing, the staff of the 
Securities and Exchange Commission (the ''Commission''), raised an issue 
regarding the existence of a beneficial conversion feature embedded in the 
Series B Convertible Preferred Stock (''Series B shares''), which should be 
accounted for as deemed dividend to the preferred shareholders. After 
consideration, the Company concluded that a beneficial conversion feature does 
exist and has quantified the amount as $3,667,000 at the issuance date. In 
addition, based on  review of the terms of the stock agreement, it has been 
determined that the Series B shares have certain mandatory redemption features. 
Although the Company believes that the likelihood of redemption occurring is 
remote, the carrying value of the Series B shares is required to be presented 
as temporary equity, which is outside of stockholders' equity.
    

The closing of the Series B Convertible Preferred Stock occurred on June 20,
1997 (the ''Issuance Date'') at an aggregate price of $6,000,000. The Company
issued 6,000 shares of preferred stock, having a stated value of $1,000 per
share, together with 100,000 warrants to purchase common stock at $9.39 per
share, and the right to an additional 100,000 warrants to purchase common stock
issuable on June 20, 1998, provided at least $2,000,000 of the preferred shares
remain outstanding at that date. The Series B shares bear no dividends and are
convertible at any time. The warrants are exercisable immediately upon issuance.
In August 1997, the common shares underlying this convertible preferred stock
and warrants were registered with the Securities and Exchange Commission
pursuant to registration rights under the Series B stock purchase agreement.

The Series B shares are convertible into common stock at a conversion price,
which at the Issuance Date, is the lower of (a) 85% of the average of the daily
low sale price for the five consecutive trading days ending two days prior to
the conversion date, or $6.01 at the Issuance date, and (b) $8.05. The number of
common shares into which the preferred stock is convertible is determined by
dividing the stated value of the preferred stock, increased on a daily basis at
a rate of 5% per annum, by the conversion price. As the Series B shares are
automatically convertible on June 20, 2002, the most beneficial conversion ratio
was determined to include the additional common shares attributable to the 5%
adjustment feature for the five-year period ending in 2002. After adjustment for
this additional benefit, the $6.01 conversion price is reduced to $4.81, the
most beneficial conversion price at the Issuance Date.

   
The Series B shares are subject to mandatory redemption requirements under 
certain limited circumstances as defined in the preferred stock agreement. 
Those circumstances include, a change in control of the Company in which more 
than 50% of the voting power of the company is disposed of, the Company's 
failure to maintain its common stock listing on the NASDAQ National Market or 
other designated stock exchange, or the Series B shares ceasing to be 
convertible as a result of the aggregate number of common shares then issuable 
upon conversion equaling 19.99% of the outstanding common stock. Should the 
Series B shares become redeemable, the redemption price would be the greater of 
(a) 118% of the stated value of the preferred stock, increased on a daily basis 
since the Issuance Date at a rate of 5% per annum, or (b) the number of shares 
issuable upon conversion multiplied by the closing price of the common stock on 
such conversion date.

The Company received $6,000,000 of proceeds, and paid offering costs of
$513,000, resulting in net proceeds of $5,487,000 for the preferred shares and
warrants. The net proceeds are being used for working capital, the acquisition
of equipment and general corporate purposes. The Company accounted for the 5%
adjustment feature as a deemed dividend by charging paid-in capital, as the
Company had an accumulated deficit, and increasing the carrying value of the
preferred stock. For the three and six month periods ended October 31, 1997, the
Company recognized deemed dividends of $66,000 and $99,000, respectively, which
were determined based on the amount of the 5% adjustment feature realizable by
the Series B stockholder during the period.

The Company has restated its financial statements at and for the six month
period ended October 31, 1997 to account for the beneficial conversion feature
and the mandatory redemption features of the Series B shares. In determining the
accounting for the beneficial conversion feature, the Company first allocated
the net proceeds of $5,487,000 to the Series B shares and the warrants based on
their relative fair values at the Issuance Date, resulting in $5,242,000
assigned to the Series B shares and $245,000 assigned to the warrants as of June
20, 1997. The Company then allocated $3,667,000 of the Series B shares net
proceeds to paid-in capital for the beneficial conversion feature resulting in a
reduction in the carrying value of the Series B shares to $1,575,000. The
beneficial conversion feature is being recognized as a deemed dividend to the
preferred shareholders over the minimum period in which the preferred
shareholders can realize that return. Because the Series B shares were
immediately convertible, a $1,732,000 deemed dividend as of the Issuance Date
has been recognized as a charge to paid-in capital and net loss applicable to
common stockholders, and an increase in the carrying value of the preferred
stock. As a result, for the six-month period ended October 31, 1997, $1,831,000
of the beneficial conversion feature has been recognized. The balance of the
beneficial conversion feature related to the outstanding Series B shares is
being recognized through June, 2002.

In September, 1997, 1,500 shares of the Series B shares were converted to
234,464 shares of common stock. The converted Series B shares had a carrying
value, including the beneficial conversion feature recognized through the date
of conversion, of $849,000. As a result of the above, the carrying value of the
Series B shares is $2,557,000 at October 31, 1997.
    

In addition, due to the mandatory redemption features noted above, the carrying
value of the Series B shares, which were previously presented as a component of
Stockholders' Equity, has been reclassified as temporary equity, outside of
Stockholders' Equity at October 31, 1997.

The restatements of the financial statements at October 31, 1997 and for the
six-month period then ended, for the matters described above had no effect on
the Company's net loss, total assets or total liabilities. The Company's
redeemable equity and total stockholders' equity at October 31, 1977 and net
loss per common share for the six months ended October 31, 1997, as previously
reported and as restated, are as follows:

   
<TABLE>
<S>                                                            <C>

Redeemable Equity - previously reported                        $    --
Adjustment related to the presentation of the
  Series B shares as redeemable                                  2,557,000
                                                               -----------
As restated                                                    $ 2,557,000
                                                               ===========

Stockholders' Equity - previously reported                     $14,220,000
Adjustment related to the presentation of the
  Series B shares as redeemable                                 (2,557,000)
                                                               -----------
As restated                                                    $11,663,000
                                                               ===========

Net Loss per Common Share - previously reported                     ($ .31)
Adjustment related to the recognition of the
  beneficial conversion feature as a deemed   
  preferred dividend                                                  (.20)
                                                               -----------
As restated                                                         ($ .51)
                                                               ===========
    
</TABLE>


                                9



<PAGE>   10

3.   In September, 1997 the Company borrowed $1,050,000 at 11.3% with a term of
four years to finance the acquisition of lasers and mobile equipment.  The debt
is collateralized by the same equipment.

4.  In October, 1997 the Company borrowed $813,000 from the lender which
provided financing in March 1997.  Under the March 1997 debt agreement, the
lender had the right to increase the percentage funded by the loan under
similar financial terms.  This debt bears interest at 13.6% with a term of four
years.


                      MANAGEMENT'S DISCUSSION AND ANALYSIS
                OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 2.
(A) LIQUIDITY AND CAPITAL RESOURCES

Since the completion of its initial public offering in April 1991, the
Company's primary sources of liquidity have consisted of financing from the
sale of Common Stock and Convertible Preferred Stock, revenues from marketing
and laser access services provided to ophthalmologists, loans and leases.  At
October 31, 1997, the Company had $7,675,000 of cash and cash equivalents
compared with $3,794,000 at April 30, 1997.  At October 31, 1997, the Company
had working capital of $5,910,000 compared with working capital of $1,654,000
at April 30, 1997.  The ratio of current assets to current liabilities at
October 31, 1997 was 1.86 to one, compared to 1.32 to one at April 30, 1997.

Cash Flows from Operating Activities

Net cash used for operating activities was $1,330,000 for the six months ended
October 31, 1997 compared to $3,041,000 for the six months ended October 31,
1996.  The cash flows used for operating activities during the six months ended
October 31, 1997 and 1996 primarily represent the net loss incurred in this
period less depreciation and amortization plus increases in accounts receivable
and prepaid expenses and other current assets partially offset by net increases
in current liabilities.  During the quarter ended October 31, 1997,
depreciation and amortization represented 103% of the net loss for the quarter.

Cash Flows from Investing Activities

Net cash used for investing activities was $2,567,000 and $4,028,000 during the
six months ended October 31, 1997 and 1996, respectively.  Cash used for
investing during the six months ended October 31, 1997 and 1996 was used to
acquire equipment for the expanding U.S. market.



                                       10



<PAGE>   11


Cash Flows from Financing Activities

Net cash provided by financing activities was $7,778,000 and $524,000 during
the six months ended October 31, 1997 and 1996, respectively.  Cash provided by
financing during the six months ended October 31, 1997 was primarily provided
by a private placement of preferred stock, proceeds from exercise of stock
options and warrants, and proceeds from loan financing, partially offset by
principal payments under capitalized lease obligations and notes payable.  Loan
proceeds, offset by lease payments, was the primary source of cash provided by
financing during the six months ended October 31, 1996.

The Company expects to continue to fund future operations and mobile
development costs from existing cash and cash equivalents, revenues received
from providing laser access and market services, the exercise of stock options
and warrants and future financing as required.  There can be no assurance that
capital will be available when needed or, if available, that the terms for
obtaining such funds will be favorable to the Company.

   
As discussed in Note 2, the Company has restated its financial statements to
account for the beneficial conversion feature and the mandatory redemption
features of its Series B Convertible Preferred Stock. The restatement resulted
in the recognition of an additional $1,732,000 deemed dividend at the Issuance
Date, which was reported as a charge to paid-in capital and net loss applicable
to common stockholders, and an increase in the carrying value of the Series B
shares. The recognition of the deemed dividend did not effect the cash flows of
the Company for the period, and subsequent recognition of additional deemed
dividends associated with the beneficial conversion feature will not effect the
Company's future cash flows. However, under certain limited circumstances, as
defined in the preferred stock agreement, the holders of the Series B shares may
be able to require the Company to redeem their shares for cash. While there can
be no assurance that those circumstances will not arise, the Company believes
the likelihood of redemption occurring is remote. Accordingly, the redemption
features of the Series B shares are not expected to adversely impact the
Company's cash flows or liquidity.
    

(B) RESULTS OF OPERATIONS

QUARTER ENDED OCTOBER 31, 1997 COMPARED TO QUARTER ENDED OCTOBER 31, 1996

The Company has continued to provide excimer laser access to additional sites
throughout the U.S.

Revenues

Total revenues of $5,224,000 for the quarter ended October 31, 1997 increased
by $3,296,000 from $1,928,000 for the quarter ended October 31, 1996, or an
increase of 171%.

Revenues for the LaserVision Centers division increased to $5,106,000 for the
quarter ended October 31, 1997 from $1,617,000 for the quarter ended October
31, 1996.  The increase is attributable to higher revenues from U.S. operations
of $3.6 million partially offset by a decrease in Canadian and European
revenues totaling $108,000.  The increase in U.S. revenues for the LaserVision
Centers division is attributable to the increased number of lasers in operation
in an increased number of markets.  During the quarter ended October 31, 1997
the Company served over 75 U.S. markets.

Revenues for the MarketVision division declined from $310,000 to $118,000 due
to the shift of attention to providing marketing services for the Company's
laser centers for which the Company does not record revenue.


Cost of Revenues/Gross Profit

Cost of revenues increased to $3,948,000 for the quarter ended October 31, 1997
from $1,830,000 for the quarter ended October 31, 1996.  Depreciation in cost
of revenue increased to $1,077,000 from


                                       11



<PAGE>   12

$944,000 in these respective periods due to the increased number of lasers and
mobile equipment in the U.S. partially offset by decreases in depreciation on
lasers which were written down to estimated fair market value during the fourth
quarter of fiscal 1997.

Other costs of revenues increased to $2,871,000 for the quarter ended October
31, 1997 from $886,000 for the quarter ended October 31, 1996 due to increased
costs, including Pillar Point royalties of $1,266,000, professional medical
services of $249,000 and mobile laser operator salaries, travel and set-up
related costs of $605,000.  These increases were partially offset by decreases
in costs of revenue for MarketVision of $97,000.  The net increase, when
combined with the revenue increase, resulted in these other costs of revenues
increasing from 46% of total revenues for the quarter ended October 31, 1996 to
55% of total revenues for the quarter ended October 31, 1997.  The increase in
these other costs of revenues as a percentage of revenues is attributable to
the change in the revenue mix to greater U.S. revenues which have greater costs
of revenue, particularly Pillar Point royalties.

Total gross profit improved from $98,000 for the quarter ended October 31, 1996
to a  profit of $1,276,000 for the quarter ended October 31, 1997.  The
variable gross profit, excluding depreciation, increased to $2,353,000 from
$1,042,000, primarily due to increased procedures in the U.S.

Operating Expenses

General and administrative expenses decreased from $785,000 to $745,000 for the
quarters ended October 31, 1996 and 1997, respectively.  The decrease is
primarily attributable to a decrease of $130,000 in legal fees associated with
tradename issues offset by increases in rent, telephone and other office
expenses of $82,000.

Salaries and related expenses increased from $815,000 to $1,067,000 for the
quarters ended October 31, 1996 and 1997, respectively.  The increase was due
to an increased number of employees to support operations, salary adjustments
and the related payroll taxes and fringe benefits.

Depreciation and amortization increased from $109,000 to $134,000 for the
quarter ended October 31,  1996 and 1997, respectively.  The increase was
primarily due to amortization of goodwill associated with the Harley Street
purchase and increased depreciation for the corporate office.

Selling and marketing expenses decreased from $520,000 to $363,000 for the
quarters ended October 31, 1996 and 1997, respectively. The decrease was
primarily due to decreased media advertising of $92,000 and a decrease of
$39,000 in travel costs.

Other Income (Expenses)

Higher interest expense caused the decline to a net $140,000 in other expenses
during the quarter ended October 31, 1997 from a net $5,000 in other expenses
during the quarter ended October 31, 1996.




                                       12



<PAGE>   13


SIX MONTHS ENDED OCTOBER 31, 1997 COMPARED TO SIX MONTHS ENDED OCTOBER 31, 1996

Revenues

Total revenues of $9,321,000 for the six months ended October 31, 1997
increased by $5,891,000 from $3,430,000 for the six months ended October 31,
1996, or an increase of 172%.

Revenues for the LaserVision Centers division increased to $8,997,000 for the
six months ended October 31, 1997 from $2,759,000 for the six months ended
October 31, 1996.  The increase is attributable to higher revenues from
European operations of $39,000 and from U.S. operations of $6.2 million
partially offset by a decrease in Canadian revenues of $46,000.  The increase
in U.S. revenues for the LaserVision Centers division is attributable to the
increased number of lasers in operation in an increased number of markets.

Revenues for the MarketVision division declined from $671,000 to $324,000 due
to the shift of attention to providing marketing services for the Company's
laser centers for which the Company does not record revenue.

Cost of Revenues/Gross Profit

Cost of revenues increased to $7,264,000 for the six months ended October 31,
1997 from $3,222,000 for the six months ended October 31, 1996.  Depreciation
in cost of revenue increased to $2,122,000 from $1,559,000 in these respective
periods due to the increased lasers and mobile equipment in the U.S. partially
offset by decreases in depreciation on lasers which were written down to
estimated fair market value during the fourth quarter of fiscal 1997.

Other costs of revenues increased to $5,142,000 for the six months ended
October 31, 1997 from $1,663,000 for the six months ended October 31, 1996 due
to increased costs, including Pillar Point royalties of $2,159,000,
professional medical services of $515,000 and mobile laser operator salaries,
travel and set-up related costs of $1,054,000.  These increases were partially
offset by decreases in costs of revenue for Market Vision of $178,000.  The net
increase, when combined with the revenue increase, resulted in these other
costs of revenues increasing from 48% of total revenues for the six months
ended October 31, 1996 to 55% of total revenues for the six months ended
October 31, 1997.  The increase in these other costs of revenues as a
percentage of revenues is attributable to the change in the revenue mix to
greater U.S. revenues which have greater costs of revenue, particularly Pillar
Point royalties.

Total gross profit improved from $208,000 for the six months ended October 31,
1996 to $2,057,000 for the six months ended October 31, 1997.  The
variable gross profit, excluding depreciation, increased to $4,179,000 from
$1,767,000, primarily due to increased laser procedures in the U.S.





                                       13



<PAGE>   14


Operating Expenses

General and administrative expenses decreased from $1,892,000 to $1,533,000 for
the six month periods ended October 31, 1996 and 1997, respectively.  The
decrease is primarily attributable to a one-time write-off of $260,000 of stock
offering costs in the quarter ended July 31, 1996, a decrease of $200,000 in
legal fees associated with tradename issues, offset by increases in rent,
telephone and other office expenses of $100,000.

Salaries and related expenses increased from $1,622,000 to $1,941,000 for the
six month periods ended October 31, 1996 and 1997, respectively.  The increase
was due to an increased number of employees to support operations,  salary
adjustments and the related payroll taxes and fringe benefits.

Depreciation and amortization increased from $208,000 to $250,000 for the six
month periods ended October 31,  1996 and 1997, respectively.  The increase was
primarily due to an increase in amortization of goodwill associated with
acquisitions of Harley Street and increased depreciation for the home office.

Selling and marketing expenses decreased from $991,000 to $716,000 for the six
month periods ended October 31, 1996 and 1997, respectively. The decrease was
primarily due to decreased marketing programs of $132,000 and decreased travel
costs of $124,000.

Other Income (Expenses)

Higher interest expense caused the decline to a net $327,000 other expenses
during the six months ended October 31, 1997, from a net $77,000 in other
income during the six months ended October 31, 1996.


                                       14



<PAGE>   15



                           PART II-OTHER INFORMATION

Item 1. Legal Proceedings
     There has been no material change in the status of any litigation from
that reported in the Form 10-K for the year ended April 30, 1997, nor has any
other material litigation been initiated.


Item 2.  Changes in Securities
                None.

Item 3.  Defaults upon Senior Securities
                None

Item 4.  Submission of Matters to a Vote of Security Holders
                None

Item 5.  Other Information
                None

Item 6.  Reports on Form 8-K during the period covered by this report:
         None.
   

Exhibit 27 - Financial Data Schedule

    


                                       15



<PAGE>   16



                                   Signature
Pursuant to the requirement of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

LASER VISION CENTERS, INC.

   

\s\John J. Klobnak                              April 21, 1999
- -------------------------                       -----------------
John J. Klobnak                                         Date
Chairman of the Board and Chief Executive Officer



\s\B. Charles Bono, III                         April 21, 1999
- -------------------------                       ----------------
B. Charles Bono Date                                    Date
Chief Financial Officer 
                        
    
                        


















                                       16






<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          APR-30-1998
<PERIOD-START>                             MAY-01-1997
<PERIOD-END>                               OCT-31-1997
<CASH>                                       7,675,000
<SECURITIES>                                         0
<RECEIVABLES>                                3,516,000
<ALLOWANCES>                                   469,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                            12,815,000
<PP&E>                                      18,760,000
<DEPRECIATION>                               5,896,000
<TOTAL-ASSETS>                              29,414,000
<CURRENT-LIABILITIES>                        6,905,000
<BONDS>                                      5,423,000
                        2,557,000
                                          0
<COMMON>                                        93,000
<OTHER-SE>                                  11,570,000
<TOTAL-LIABILITY-AND-EQUITY>                29,414,000
<SALES>                                      9,321,000
<TOTAL-REVENUES>                             9,321,000
<CGS>                                        7,264,000
<TOTAL-COSTS>                                7,264,000
<OTHER-EXPENSES>                             4,440,000
<LOSS-PROVISION>                               109,000
<INTEREST-EXPENSE>                             471,000
<INCOME-PRETAX>                            (2,710,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,710,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,710,000)
<EPS-PRIMARY>                                    (.51)
<EPS-DILUTED>                                    (.51)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission